PNEUMOCYSTIS JIROVECII PNEUMONIA IN HOSPITALIZED CANCER PATIENTS: INCIDENCE, RISK FACTORS, AND PROPHYLAXIS

被引：0
|
作者：
Van Hook, Reed
Mantha, Aditya
Rhoads, Sarah L.
Spradlin, Megan
Pons, Shelby
Mccollister, Bruce
Mueller, Scott
Kannappan, Arun
Maloney, James P.
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.597
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：801A / 802A
页数：2
相关论文
共 50 条
  • [21] Pneumocystis jirovecii Pneumonia in Neurologic Disorders Is Prophylaxis Necessary?
    Pike-Lee, Tiffany
    Syed, Sana
    Willis, Mary Alissa
    Li, Yuebing
    NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (03) : 242 - 248
  • [22] Risk factors and clinical characteristics for Pneumocystis jirovecii pneumonia in Japanese patients with ulcerative colitis
    Sato, T.
    Koshiba, R.
    Kojima, K.
    Fujimoto, K.
    Kawai, M.
    Kamikoduru, K.
    Yokoyama, Y.
    Takagawa, T.
    Uchino, M.
    Hida, N.
    Watanabe, K.
    Miwa, H.
    Ikeuchi, H.
    Nakamura, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S144 - S145
  • [23] Characterization and associated risk factors of Pneumocystis Jirovecii pneumonia in patients with AIRD: a retrospective study
    Zhao, Zichu
    Huang, Yanli
    Ming, Bingxia
    Zhong, Jixin
    Dong, Lingli
    RHEUMATOLOGY, 2022, 61 (09) : 3766 - 3776
  • [24] PNEUMOCYSTIS JIROVECII PROPHYLAXIS IN PATIENTS ON RITUXIMAB
    Warrier, Kishore
    Salvesani, Catherine
    Deepak, Samundeeswari
    RHEUMATOLOGY, 2019, 58
  • [25] Incidence of Pneumocystis Jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients with Systemic Lupus Erythematosus
    Jiang, Yiran
    Duarte-Garcia, Ali
    Putman, Mike
    Gazeley, David
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3158 - 3159
  • [26] CLINICAL CHARACTERISTICS AND RISK FACTORS FOR PNEUMOCYSTIS JIROVECII PNEUMONIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Sato, Toshiyuki
    Uchino, Motoi
    Koshiba, Ryoji
    Kojima, Kentaro
    Fujimoto, Koji
    Kawai, Mikio
    Kamikozuru, Koji
    Yokoyama, Yoko
    Takagawa, Tetsuya
    Hida, Nobuyuki
    Watanabe, Kenji
    Ikeuchi, Hiroki
    Nakamura, Shiro
    GASTROENTEROLOGY, 2019, 156 (06) : S634 - S634
  • [27] Epidemiology and Impact of Pneumocystis jirovecii Pneumonia in Hospitalized Patients With Inflammatory Bowel Disease
    Shah-Khan, Sardar M.
    Shah-Khan, Musa
    Kupec, Justin T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S399 - S399
  • [28] Incidence of Pneumocystis jirovecii pneumonia (PJP) in patients receiving BTK inhibitors who did not receive PJP prophylaxis
    Davis, James A.
    Graham, Anastasia
    Hendrickson, Lindsey
    Hess, Brian
    Gaffney, Kelly
    LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 2016 - 2018
  • [29] Risk Factors For Pneumocystis Jirovecii Pneumonia (pcp) In Kidney Transplantation Recipients
    Lee, S.
    Joo, D.
    Kim, M.
    Kim, Y.
    Park, M.
    Kim, Y.
    Kim, S.
    Chang, J.
    Kim, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [30] Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
    Su Hwan Lee
    Kyu Ha Huh
    Dong Jin Joo
    Myoung Soo Kim
    Soon Il Kim
    Juhan Lee
    Moo Suk Park
    Young Sam Kim
    Se Kyu Kim
    Joon Chang
    Yu Seun Kim
    Song Yee Kim
    Scientific Reports, 7
12345